ArticleActa pharmaceutica Sinica. B2025
Erratum: Author correction to "PRMT6 promotes tumorigenicity and cisplatin response of lung cancer through triggering 6PGD/ENO1 mediated cell metabolism" [Acta Pharm Sin B 13 (2023) 157-173].
Mingming Sun et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.